Advanced Diagnostic Solutions
AccessDx Laboratory provides advanced diagnostic solutions for personalized medicine, infectious disease programs, and COVID-19 testing. AccessDx Laboratory technologies include advanced molecular diagnostics platforms, next generation sequencing capabilities, and high throughput sample processing capabilities. AccessDx Lab has proven its expertise and the scalability of its platforms for thousands of client groups including large national health systems, municipalities, long-term care organizations, employers, pharmacists, and providers.
COVID-19 Diagnostic Solutions
COVID-19 Infection Testing
AccessDx offers a range of high-accuracy, fast-turnaround COVID-19 diagnostic solutions to meet the demanding needs of clinical providers, employers, care facilities, and municipalities. Laboratory COVID-19 PCR tests quickly identify the SARS-CoV-2 virus so effective actions can begin sooner, and AccessDx Lab supports testing workflows for surveillance, compliance, and outbreak containment. AccessDx Lab’s suite of software solutions facilitates streamlined test ordering, sample logistics, and reporting. AccessDx Lab’s RT-PCR tests have been made available pursuant to the FDA’s Emergency Use Authorization (EUA) for diagnostic testing in CLIA-certified laboratories.
COVID-19 Antibody
AccessDx Lab provides both laboratory-based and high-quality rapid COVID-19 Antibody test solutions as a complement to infection testing programs. The AccessDx laboratory-based antibody tests provide fast turnaround, high-quality serology results that can aid clinicians in their assessment of infected and recovered patients. Antibody tests are available pursuant to the FDA’s emergency use authorization (EUA) outlined for COVID-19 diagnostic tests.
Personalized Diagnostics
Pharmacogenomics and Personalized Medication Management (PGx)
AccessDx Pharmacogenomics solutions utilize the latest in high-quality evidence based-science to maximize clinical impact and empower clinical decision support. AccessDx Lab offers a range of panels and program designs to benefit combinatorial medication risk assessments, specialty medication analysis, and clinical research programs. When combined with the MedTek21 clinical decision support program, providers can seamlessly integrate pharmacogenomics within their clinical workflow and existing EMR platforms.
Hereditary Cancer Testing (CGx)
The AccessDx Hereditary Cancer (CGx) screening assay analyzes causative variants involved in some of the most common hereditary cancers with relatively high population occurrences. This molecular diagnostics program enables clinical providers and patients to make proactive decisions about prevention options, lifestyle choices, and potential therapies.
Infectious Disease Diagnostics
Gastrointestinal Pathogen Panel (GI)
The AccessDx Gastrointestinal Pathogen Panel quickly identifies several enteropathogenic viruses, bacteria, and parasites responsible for gastroenteritis by utilizing multiplex quantitative Real-Time PCR. It precisely detects the pathogens during single or coinfections and identifies antibiotic drug resistance in one single test. It also facilitates antibiotic stewardship by pinpointing situations for which antibiotics should be avoided.
Nail Pathogen Panel (NPP)
With the AccessDx Nail Pathogen Panel, physicians can identify a fungal toenail infection quickly with the added benefit of species identification. The panel can detect both fungi and bacteria from the microbial nail flora.
Respiratory Pathogen Panel (RPP)
The AccessDx Laboratory Respiratory Pathogen Panel rapidly detects and differentiates a wide range of viral and bacterial pathogens so effective treatment can begin sooner.
Urinary Tract Infection Panel
Urinary tract infections (UTIs) are the most common infections requiring medical attention and a leading justification for antibiotic prescription. AccessDx molecular diagnostic test accurately detects uropathogens and improves treatment selection while preserving antibiotic stewardship. These enhancements in both speed and accuracy compared with traditional detection methods improve the clinical decisioning process, drive lower overall care costs and readmits, improve outcomes, and creating operational efficiencies for the healthcare team.
Wound Pathogen Panel (WPP)
The AccessDx Laboratory Wound Pathogen Panel (WPP) rapidly establishes the microbiological profile of a sample and simultaneously reveals antibiotic resistance genes. This diagnostic uses a molecular-based analysis platform that provides enhanced precision and speed for species identification when compared to conventional cultures.
